The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.
A decade after bringing Transcatheter Aortic Valve Replacement (TAVR) to Alaska, doctors at Providence Alaska Medical Center ...
The DapaTAVI trial assessed the benefits of dapagliflozin in patients discharged after TAVI with a history of heart failure plus 1 of the following comorbidities: LVEF ≤40%, diabetes, or renal ...
BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...
Medtronic has issued a recall for several aortic root cannula devices due to a potential safety risk that could cause loose ...
Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...
New research suggests cerebral embolic protection devices do not lower the risk of stroke in patients undergoing ...
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...
The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...